drugset / Trial / NCT01544972

Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants

NCT01544972 ↗

RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose of this study is to determine oral paracetamol and ibuprofen efficacy and safety in relation to serum levels in closure of patent ductus arteriosus in preterm infants.

Timeline

Start
2012-02
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 15 mg/kg Oral
Comparator Ibuprofen Small molecule 5 mg/kg Oral